HomeNewsBusinessReal Estate79% of workforce favours working remotely from home at least once a week: Survey

79% of workforce favours working remotely from home at least once a week: Survey

Going forward, as many as 91 percent of the workforce want to choose their schedules.

September 01, 2021 / 22:34 IST
Story continues below Advertisement
A graphic representation of an employee working from home. (PC-Shutterstock)
A graphic representation of an employee working from home. (PC-Shutterstock)

An ideal working week, post COVID-19, seems to be one where as many as 79 percent of the workforce wants to work remotely from home at least once a week, according to JLL’s Workers Preference Barometer for India.

Post the pandemic, employees prefer spending three days working remotely and two days in office, with office remaining a key element to the aspirational working regime, it said.

Story continues below Advertisement

According to the survey, 21 percent of the workforce does not want to work from home in the future, as opposed to 16 percent in October last year. However, flexibility is becoming more attractive.

As many as 91 percent of the workforce want to choose their schedules and working hours as per the latest results, up from 69 percent as per the October 2020 survey results, it said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show